St John's Wort in depression: The patient's dilemma

Primary Care and Community Psychiatry

Volumn 11, Issue 3, 2006, Pages 137-142

  Wheatley, David ^a  

^a SOUTH LONDON AND MAUDSLEY NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 83455211494     PISSN: 17468841     EISSN: None     Source Type: Journal    
DOI: 10.1185/135525706X132893     Document Type: Review

References (33)

1. Wheatley D. Side-effects are no problem with St John's Wort in depression. Prim Care Psychiatry. 2002;8:31-3 (Pubitemid 34601047)
2. Wheatley D. Current role of herbal preparations. In: Preskorn SH, Feighner JP, Stanga CY and Ross R, editors. Handbook of experimental pharmacology, volume 157. Berlin: Springer; 2004. p. 326-51
3. Nahrstedt A, Butterweck V. Biologically active and other chemical constituents of the herb of hypericum perforatum L. Pharmacopsychiatry. 1997;30 Suppl 2:129-34
4. Cott JM. In vitro receptor binding and enzyme inhibition by hypericum perforatum extract. Pharmacopsychiatry. 1997;30 Suppl 2:108-12 (Pubitemid 27414449)
5. Muller WE, Singer A, Wonnemann M, Hafner U, Rolli M, Schafer C. Hyperforin represents the neurotransmitter reuptake inhibiting constituent of hypericum extract. Pharmacopsychiatry. 1998;31 Suppl 1:16-21 (Pubitemid 28294221)
6. Teufel-Mayer R, Gleitz J. Effects of long-term administration of hypericum extracts on the affinity and density of the central serotonergic HT1 A and HT2 A receptors. Pharmacopsychiatry. 1997;30 Suppl 2:113-6
7. Ozturk Y, Aydin S, Ozturk N, Baser KHC. Effects of certain hypericum species on the central nervous system of mice. 2nd International Congress on Phytomedicine. 11-14 September 1996, Munich, Germany
8. Chatterjee SS, Bhattacharya SK, Wonnemann M, Singer A, Muller WE. Hyperforin as a possible antidepressant component. of hypericum extracts. Life Sci. 1998;63(6):499-510 (Pubitemid 28367402)
9. Bennett DA Jr., Phun L, Polk JF, Voglino SA, Zlotnik V, Raffa RB. Neuropharmacology of St John's Wort (hypericum). Ann Pharmacother. 1989;32(11):1201-8
10. Simbrey K, Winterhoff H, Butterweck V. Extract of St John's Wort and various constituents affect β-adrenergic binding in rats frontal cortex. Life Science. 2004;74:1027-38 (Pubitemid 37522136)
11. Butterweck V, Nahrstedt A, Evans J, et al. In vitro receptor screening of pure constituents of St John's Wort reveals novel interactions with a number of GPCRs. Psychopharmacology 2002;162:193-202 (Pubitemid 34743959)
12. Ozturk Y. Testing of antidepressant effects of hypericum species on animal models. Pharmacopsychiatry. 1997;30 Suppl 2:125-8
13. Winterhoff H, Butterweck V, Nahrstedt A, Gumbinger HG, Schulz V, Erping S et al. Pharmakologische Untersuchungen zur antidepressiven Wirkung von hypericum perforatum L. In: Phytopharmaka in forschung und klinischer anwendung. Loew D, Rietbrock N, editors. Darmstadt: Steinkopf; 1995. p. 39-56
14. Butterweck V. Mechanism of action of St John's Wort in depression: what is known? CNS Drugs. 2003;17:539-62 (Pubitemid 36774135)
15. Linde K, Berner M, Egger M, Mulrow C. St John's Wort for depression: meta-analysis of randomized controlled trials. Br. J. Psychiatry. 2005;186:99-107 (Pubitemid 40193777)
16. Wheatley D. LI 160, an extract of St John's Wort, versus amitriptyline in mildly to moderately depressed outpatients - a controlled 6 week clinical trial. Pharmacopsychiatry. 1997;30 Suppl 2:77-80
17. Lecrubier Y, Clerc G, Didi R, Kieser M. Efficacy of St John's Wort extract WS5570 in major depression: a double-blind, placebo-controlled trial. Am J Psychiatry. 2002;159:1361-6 (Pubitemid 34832718)
18. Philipp M, Kohnen R, Hiller KO. Hypericum extract versus imipramine or placebo in patients with moderate depression: randomised multicentre study of treatment for eight weeks. BMJ. 1999;319:1534-8
19. Schrader E. Equivalence of St John's Wort extract (Ze 117) and fluoxetine: a randomized, controlled study in mild-moderate depression. Int Clin Psychopharmacol. 2000;15;61-8 (Pubitemid 30142797)
20. Fava M, Alpert J, Nierenberg AA, Mischoulon D, Otto MW, Zajecka J et al. A double-blind, randomized trial of St John's Wort, fluoxetine, and placebo in major depressive disorder. J Clin Psychopharmacol. 2005;25:441-7 (Pubitemid 41368366)
21. Szegedi A, Kohnen R, Dienel A, Kieser M. Acute treatment of moderate to severe depression with hypericum extract WS 5570 (St John's Wort): randomised controlled double blind non-inferiority trial versus paroxetine. BMJ. 2005;330:503-6 (Pubitemid 40343350)
22. Hypericum Depression Trial Study Group. Effect of hypericum perforatum (St John's Wort) in major depressive disorder: a randomized controlled trial. JAMA. 2002;287:1807-14
23. Murphy PA, Kern SE, Stanczyk FZ, Westhoff CL. Interaction of St John's Wort with oral contraceptives: effects on the pharmacokinetics of norethindrone and ethinyl estradiol, ovarian activity and breakthrough bleeding. Contraception. 2005;71:402-8 (Pubitemid 40725774)
24. Hall SD, Wang Z, Huang SM, Hamman MA, Vasavada NA, Adigun AQ et al. The interaction between St John's Wort and an oral contraceptive. Clin Pharmacol Ther. 2003;74:525-35 (Pubitemid 37521996)
25. Leuschner J. Preclinical toxicological profile of hypericum Extract LI 160 (abstract). Phytomedicine. 1996/7;3(Suppl 1): 34-8
26. Stevinson C, Ernst E. Safety of hypericum in patients with depression: a comparison with conventional antidepressants. CNS Drugs. 1999;11:125-3.
27. Bove GM. Acute neuropathy after exposure to sun in a patient treated with John's Wort. Lancet. 1998;352:1121-2 (Pubitemid 28448527)
28. Butterweck V. Mechanism of action of St John's Wort in depression. CNS Drugs. 2003;17:539-62 (Pubitemid 36774135)
29. Barnes J, Barber N, Wheatley D, Williamson EM. A pilot randomised, open, uncontrolled, clinical study of two dosages of St John's Wort (hypericum perforatum) herb extract (LI-160) as an aid to motivational/behavioural support in smoking cessation. Planta Med. 2006;72:378-82
30. Wright CW, Gott M, Grayson B, Hanna M, Smith AG, Sunter A et al. Correlation of hyperforin content of hypericum perforatum (St John's Wort) extracts with their effects on alcohol drinking in C57BL/6J mice: a preliminary study. J Psychopharmacol. 2003;17:403-8 (Pubitemid 38076335)
31. Perfumi M, Mattiolli L, Cucculelli M, Massi M. Reduction of ethanol intake by chronic treatment with hypericum perforatum, alone or combined with naltrexone in rats. J Psychopharmacol. 2005;19:448-54 (Pubitemid 41392298)
32. Nanayakkara PWB, Meijboom M, Schouten JA. Suicidal and aggressive thoughts as a result of taking a Hypericum preparation (St John's Wort). Ned Tijdschr Geneeskd. 2005;149:1347-9 (Pubitemid 40834545)
33. Davidson JRT, Connor KM. St John's Wort in generalized anxiety disorder: three case reports. J Clin Psychopharmacol. 2001;21:635-6 (Pubitemid 33116676)